ArticleVaccines2026

A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response.

Dieter Volc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.